Cost of treating patients with smoking history in a specialized cancer hospital
Autor(a) principal: | |
---|---|
Data de Publicação: | 2011 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/6024 |
Resumo: | To the team of the Health Technology Assessment Center of the National Cardiology Institute for statistical analysis support. |
id |
CRUZ_d5e7a67d0e4979d7387c999d528e8bd2 |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/6024 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Pinto, MárciaUgá, Maria Alicia Domínguez2012-12-18T18:10:36Z2012-12-18T18:10:36Z2011PINTO, Márcio; UGÁ, Maria Alicia Domínguez. Cost of treating patients with smoking history in a specialized cancer hospital. Rev. Saúde Pública. São Paulo, v. 45, n. 3, p. 1-7, 2011.0034-8910https://www.arca.fiocruz.br/handle/icict/602410.1590/S0034-89102011005000026To the team of the Health Technology Assessment Center of the National Cardiology Institute for statistical analysis support.OBJETIVO: Describir el costo del tratamiento de los cánceres de pulmón, laringe y esófago de pacientes con historia de tabaquismo. MÉTODOS: Estudio longitudinal no concurrente de tres cohortes con historia de tabaquismo en un hospital especializado en la ciudad de Rio de Janeiro, Sureste de Brasil, entre 2000 y 2006. La muestra fue compuesta por 127 casos de cáncer de pulmón, 80 de cáncer de laringe y 35 de cáncer de esófago. La selección de los cánceres fue realizada por medio del análisis de la frecuencia y del valor monetario de las hospitalizaciones, ponderados por la fracción atribuible al tabaco en la población. Los datos fueron colectados de los prontuarios. Los pacientes fueron clasificados conforme el perfil de tabaquismo, el diagnóstico principal, la fase y las comorbilidades. El análisis estadístico incluyó la distribución log-normal para ajustar los valores del costo y la correlación de Spearman. RESULTADOS: Los pacientes eran fumadores pesados y fueron diagnosticados en fases avanzadas. La carga tabáquica fue elevada y 92% de los pacientes con cáncer de pulmón, 72% con cáncer de laringe y 94% con cáncer de esófago fueron diagnosticados en fases avanzadas. Las comorbilidades más frecuentes fueron las enfermedades cardíacas y las respiratorias. El costo promedio fue de R$ 28.901, R$ 37.529 y R$ 33.164 para cáncer de pulmón, laringe y esófago, respectivamente. Los principales responsables por el costo fueron la radioterapia y la hospitalización. Se observó asociación entre fases avanzadas y menor costo para cáncer de pulmón y de esófago. CONCLUSIONES: Siendo la radioterapia y hospitalización los principales responsables por el costo total, los pacientes en fases más graves presentaron costos menores probablemente por la reducción de las opciones terapéuticas.Fundação Oswaldo Cruz. Instituição Fernandes Figueira. Núcleo de Avaliação de Tecnologias em Saúde. Rio de Janeiro, RJ, BrasilFundação Oswaldo Cruz. Escola Nacional de Saúde Pública Sergio Arouca. Rio de Janeiro, RJ, BrasilOBJECTIVE: To describe the costs of treating lung, laryngeal and esophageal cancer among patients with histories of smoking. METHODS: A longitudinal non-concurrent study on three cohorts with histories of smoking at a specialized hospital was carried out in the city of Rio de Janeiro, Southeastern Brazil, between 2000 and 2006. The sample was composed of 127 cases of lung cancer, 80 of laryngeal cancer and 35 of esophageal cancer. These cancers were selected through analyzing the frequencies and monetary values of the hospital admissions, weighted according to the fraction attributable to smoking among the population. Data were gathered from the medical files. Patients were classified according to their smoking profile, primary diagnosis, stage and comorbidities. The statistical analysis included the log-normal distribution to adjust for cost values and the Spearman correlation. RESULTS: The patients were heavy smokers and were diagnosed at advanced stages. The burden from smoking was high, and 92%, 72% and 94% of lung, laryngeal and esophageal cancer patients, respectively, were diagnosed at advanced stages. The most frequent comorbidities were heart diseases and respiratory diseases. The mean costs of lung, laryngeal and esophageal cancers were R$ 28,901, R$ 37,529 and R$ 33,164, respectively. The main cost drivers were radiotherapy and hospitalization. There was an association between advanced stage and lower cost for lung and esophageal cancer. CONCLUSIONS: Since radiotherapy and hospitalization were the main total cost drivers, patients at more severe stages presented lower costs, probably because of the reduction in the number of therapeutic options.engFaculdade de Saúde Pública da Universidade de São PauloArnold D, Funk GF, Karnell LH, Chen AH, Hoffman HT, Ricks JM, et al. Laryngeal cancer cost analysis: association of case-mix and treatment characteristics with medical charges. Laryngoscope. 2000;110(1):1-7. DOI:10.1097/00005537-200001000-00001Brinkman GL, Coates Jr EO. The effects of bronchitis, smoking and occupation on ventilation. Ann Rev Respir Dis. 1963;87:684-93.Cersosimo RJ. Lung cancer: a review. Am J Health Syst Pharm. 2002;59(7):611-42.Corrêa PCRP, Barreto SM, Passos VMA. Smoking-attributable mortality and years of potential life lost in 16 Brazilian capitals, 2003: a prevalence-based study. BMC Public Health. 2009;9: 206. DOI:10.1186/1471-2458-9-206.anaei G, Vander Hoorn S, Lopez AD, Murray CJL, Ezzati M. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet. 2005;366(9499):1784-93. DOI:10.1016/S0140-6736(05)67725-2.Dedes KJ, Szucs TD, Bodis S, Joerger M, Lowy A, Russi EW, et al. Management and costs of treating lung cancer patients in a universitary hospital. Pharmacoeconomics. 2004;22(7):435-44.Haire-Joshu D, Glasgow RE, Tibbs TL. Smoking and diabetes. Diabetes Care. 1999;22(11):1887-98. DOI:10.2337/diacare.22.11.1887.Hillner BE, McDonald MK, Desch CE, Smith TJ, Penberthy L, Maddox P, et al. Costs of care associated with non-small-cell lung cancer in a commercially insured cohort. J Clin Oncol. 1998;16(4):1420-4.Izumi Y, Tsuji I, Ohkubo T, Kuwahara A, Nishino, Hisamichi S. Impact of smoking habit on medical care and its costs: a prospective observation of National Health Insurance beneficiaries in Japan. Int J Epidemiol. 2001;30(3):616-21. DOI:10.1093/ije/30.3.616.Janssen-Heijnen MLG, Schipper RM, Razemberg PPA, Crommelin MA, Coebergh JWW. Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study. Lung Cancer. 1998; 21(2):105-13.Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442. DOI:10.1371/journal.pmed.0030442.Medici AC, Marques RM. Sistemas de custos como instrumento de eficiência e qualidade dos serviços de saúde. Cad Fundap. 1996;(19):47-59.Neubauer S, Welte R, Beiche A, Koenig HH, Buesch K, Leidl R. Mortality, morbidity and costs attributable to smoking in Germany: update and a 10-year comparison. Tob Control. 2006;15(6):464-71. DOI:10.1136/tc.2006.016030Oliveira AF, Valente JG, Leite IC. Aspectos da mortalidade atribuível ao tabaco: revisão sistemática. Rev Saude Publica. 2008;42(2):335-45. DOI:10.1590/S0034-89102008005000001Shafey O, Eriksen M, Ross H, Mackay J. The tobacco atlas. 3ºed. Atlanta: American Cancer Society; 2009.Soni A, Sonnenberg A. Health resource utilization in the management of oesophageal adenocarcinoma. Aliment Pharmacol Ther. 2001;15(7):945-51. DOI:10.1046/j.1365-2036.2001.01004.xStewart BW, Kleihues P, editors. World cancer report. Lyon: IARC Press; 2003.Thuler FP, Forones NM, Ferrari AP. Neoplasia avançada de esôfago: diagnóstico ainda muito tardio. Arq Gastroenterol. 2006;43(3):206-11. DOI:10.1590/S0004-28032006000300010.Toh CK, Gao F, Lim WT, Leong SS, Fong KW, Yap SP, et al. Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity. J Clin Oncol. 2006;24(15):2245-51. DOI:10.1200/JCO.2005.04.8033.Tomasich FDS, Valladares GCG, Demarchi VCA, Gagliardi D. Influência do tratamento neoadjuvante na morbi-mortalidade das esofagectomias. Rev Assoc Med Bras. 2003;49(3):300-5. DOI:10.1590/S0104-42302003000300035.US Department of Health and Human Services. Reducing the health consequences of smoking: 25 years of progress: a report of the surgeon general. Rockville, MD: Public Health Service, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 1989. (DHHS Publication, 89-8411).Van Agthoven, van Inevel BM, de Boer MF, Leemans CR, Knegt PP, Snow GB, et al. The costs of head and neck oncology: primary tumors, recurrent tumors long-term follow-up. Eur J Cancer. 2001;37(17):2204-11.Wolstenholme JL, Whynes DK. The hospital costs of treating lung cancer in the United Kingdom. Br J Cancer. 1999;80(1/2):215-8. DOI:10.1038/sj.bjc.6690341.Wünsch Filho V. The epidemiology of laryngeal cancer in Brazil. Sao Paulo Med J. 2004;122(5):188-94. DOI:10.1590/S1516-31802004000500002.Cost of treating patients with smoking history in a specialized cancer hospitalCosto del tratamiento de pacientes con historia de tabaquismo en hospital especializado en cáncerinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleSmokingNeoplasmsHealth Care CostsCohort StudiesTabaquismoNeoplasiasCostos de la Atención en SaludEstudios de CohortesTabagismoCustos de Cuidados de SaúdeNeoplasiasEstudos de Coortesinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZORIGINALCost of treating patients with smoking history in a specialized cancer hospital.pdfCost of treating patients with smoking history in a specialized cancer hospital.pdfapplication/pdf186690https://www.arca.fiocruz.br/bitstream/icict/6024/1/Cost%20of%20treating%20patients%20with%20smoking%20history%20in%20a%20specialized%20cancer%20hospital.pdf7529a9774d646ed86751a0f636340181MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-81914https://www.arca.fiocruz.br/bitstream/icict/6024/2/license.txt7d48279ffeed55da8dfe2f8e81f3b81fMD52TEXTCost of treating patients with smoking history in a specialized cancer hospital.pdf.txtCost of treating patients with smoking history in a specialized cancer hospital.pdf.txtExtracted texttext/plain30882https://www.arca.fiocruz.br/bitstream/icict/6024/5/Cost%20of%20treating%20patients%20with%20smoking%20history%20in%20a%20specialized%20cancer%20hospital.pdf.txtb827bd69463c601c81ec4572f9775037MD55THUMBNAILCost of treating patients with smoking history in a specialized cancer hospital.pdf.jpgCost of treating patients with smoking history in a specialized cancer hospital.pdf.jpgGenerated Thumbnailimage/jpeg1861https://www.arca.fiocruz.br/bitstream/icict/6024/4/Cost%20of%20treating%20patients%20with%20smoking%20history%20in%20a%20specialized%20cancer%20hospital.pdf.jpga4d1ac29d215d47317c4674238277399MD54icict/60242018-04-06 09:02:52.674oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352018-04-06T12:02:52Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.pt_BR.fl_str_mv |
Cost of treating patients with smoking history in a specialized cancer hospital Costo del tratamiento de pacientes con historia de tabaquismo en hospital especializado en cáncer |
title |
Cost of treating patients with smoking history in a specialized cancer hospital |
spellingShingle |
Cost of treating patients with smoking history in a specialized cancer hospital Pinto, Márcia Smoking Neoplasms Health Care Costs Cohort Studies Tabaquismo Neoplasias Costos de la Atención en Salud Estudios de Cohortes Tabagismo Custos de Cuidados de Saúde Neoplasias Estudos de Coortes |
title_short |
Cost of treating patients with smoking history in a specialized cancer hospital |
title_full |
Cost of treating patients with smoking history in a specialized cancer hospital |
title_fullStr |
Cost of treating patients with smoking history in a specialized cancer hospital |
title_full_unstemmed |
Cost of treating patients with smoking history in a specialized cancer hospital |
title_sort |
Cost of treating patients with smoking history in a specialized cancer hospital |
author |
Pinto, Márcia |
author_facet |
Pinto, Márcia Ugá, Maria Alicia Domínguez |
author_role |
author |
author2 |
Ugá, Maria Alicia Domínguez |
author2_role |
author |
dc.contributor.author.fl_str_mv |
Pinto, Márcia Ugá, Maria Alicia Domínguez |
dc.subject.en.pt_BR.fl_str_mv |
Smoking Neoplasms Health Care Costs Cohort Studies |
topic |
Smoking Neoplasms Health Care Costs Cohort Studies Tabaquismo Neoplasias Costos de la Atención en Salud Estudios de Cohortes Tabagismo Custos de Cuidados de Saúde Neoplasias Estudos de Coortes |
dc.subject.es.pt_BR.fl_str_mv |
Tabaquismo Neoplasias Costos de la Atención en Salud Estudios de Cohortes |
dc.subject.decs.pt_BR.fl_str_mv |
Tabagismo Custos de Cuidados de Saúde Neoplasias Estudos de Coortes |
description |
To the team of the Health Technology Assessment Center of the National Cardiology Institute for statistical analysis support. |
publishDate |
2011 |
dc.date.issued.fl_str_mv |
2011 |
dc.date.accessioned.fl_str_mv |
2012-12-18T18:10:36Z |
dc.date.available.fl_str_mv |
2012-12-18T18:10:36Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
PINTO, Márcio; UGÁ, Maria Alicia Domínguez. Cost of treating patients with smoking history in a specialized cancer hospital. Rev. Saúde Pública. São Paulo, v. 45, n. 3, p. 1-7, 2011. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/6024 |
dc.identifier.issn.none.fl_str_mv |
0034-8910 |
dc.identifier.doi.none.fl_str_mv |
10.1590/S0034-89102011005000026 |
identifier_str_mv |
PINTO, Márcio; UGÁ, Maria Alicia Domínguez. Cost of treating patients with smoking history in a specialized cancer hospital. Rev. Saúde Pública. São Paulo, v. 45, n. 3, p. 1-7, 2011. 0034-8910 10.1590/S0034-89102011005000026 |
url |
https://www.arca.fiocruz.br/handle/icict/6024 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.isbasedon.pt_BR.fl_str_mv |
Arnold D, Funk GF, Karnell LH, Chen AH, Hoffman HT, Ricks JM, et al. Laryngeal cancer cost analysis: association of case-mix and treatment characteristics with medical charges. Laryngoscope. 2000;110(1):1-7. DOI:10.1097/00005537-200001000-00001 Brinkman GL, Coates Jr EO. The effects of bronchitis, smoking and occupation on ventilation. Ann Rev Respir Dis. 1963;87:684-93. Cersosimo RJ. Lung cancer: a review. Am J Health Syst Pharm. 2002;59(7):611-42. Corrêa PCRP, Barreto SM, Passos VMA. Smoking-attributable mortality and years of potential life lost in 16 Brazilian capitals, 2003: a prevalence-based study. BMC Public Health. 2009;9: 206. DOI:10.1186/1471-2458-9-206. anaei G, Vander Hoorn S, Lopez AD, Murray CJL, Ezzati M. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet. 2005;366(9499):1784-93. DOI:10.1016/S0140-6736(05)67725-2. Dedes KJ, Szucs TD, Bodis S, Joerger M, Lowy A, Russi EW, et al. Management and costs of treating lung cancer patients in a universitary hospital. Pharmacoeconomics. 2004;22(7):435-44. Haire-Joshu D, Glasgow RE, Tibbs TL. Smoking and diabetes. Diabetes Care. 1999;22(11):1887-98. DOI:10.2337/diacare.22.11.1887. Hillner BE, McDonald MK, Desch CE, Smith TJ, Penberthy L, Maddox P, et al. Costs of care associated with non-small-cell lung cancer in a commercially insured cohort. J Clin Oncol. 1998;16(4):1420-4. Izumi Y, Tsuji I, Ohkubo T, Kuwahara A, Nishino, Hisamichi S. Impact of smoking habit on medical care and its costs: a prospective observation of National Health Insurance beneficiaries in Japan. Int J Epidemiol. 2001;30(3):616-21. DOI:10.1093/ije/30.3.616. Janssen-Heijnen MLG, Schipper RM, Razemberg PPA, Crommelin MA, Coebergh JWW. Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study. Lung Cancer. 1998; 21(2):105-13. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442. DOI:10.1371/journal.pmed.0030442. Medici AC, Marques RM. Sistemas de custos como instrumento de eficiência e qualidade dos serviços de saúde. Cad Fundap. 1996;(19):47-59. Neubauer S, Welte R, Beiche A, Koenig HH, Buesch K, Leidl R. Mortality, morbidity and costs attributable to smoking in Germany: update and a 10-year comparison. Tob Control. 2006;15(6):464-71. DOI:10.1136/tc.2006.016030 Oliveira AF, Valente JG, Leite IC. Aspectos da mortalidade atribuível ao tabaco: revisão sistemática. Rev Saude Publica. 2008;42(2):335-45. DOI:10.1590/S0034-89102008005000001 Shafey O, Eriksen M, Ross H, Mackay J. The tobacco atlas. 3ºed. Atlanta: American Cancer Society; 2009. Soni A, Sonnenberg A. Health resource utilization in the management of oesophageal adenocarcinoma. Aliment Pharmacol Ther. 2001;15(7):945-51. DOI:10.1046/j.1365-2036.2001.01004.x Stewart BW, Kleihues P, editors. World cancer report. Lyon: IARC Press; 2003. Thuler FP, Forones NM, Ferrari AP. Neoplasia avançada de esôfago: diagnóstico ainda muito tardio. Arq Gastroenterol. 2006;43(3):206-11. DOI:10.1590/S0004-28032006000300010. Toh CK, Gao F, Lim WT, Leong SS, Fong KW, Yap SP, et al. Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity. J Clin Oncol. 2006;24(15):2245-51. DOI:10.1200/JCO.2005.04.8033. Tomasich FDS, Valladares GCG, Demarchi VCA, Gagliardi D. Influência do tratamento neoadjuvante na morbi-mortalidade das esofagectomias. Rev Assoc Med Bras. 2003;49(3):300-5. DOI:10.1590/S0104-42302003000300035. US Department of Health and Human Services. Reducing the health consequences of smoking: 25 years of progress: a report of the surgeon general. Rockville, MD: Public Health Service, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 1989. (DHHS Publication, 89-8411). Van Agthoven, van Inevel BM, de Boer MF, Leemans CR, Knegt PP, Snow GB, et al. The costs of head and neck oncology: primary tumors, recurrent tumors long-term follow-up. Eur J Cancer. 2001;37(17):2204-11. Wolstenholme JL, Whynes DK. The hospital costs of treating lung cancer in the United Kingdom. Br J Cancer. 1999;80(1/2):215-8. DOI:10.1038/sj.bjc.6690341. Wünsch Filho V. The epidemiology of laryngeal cancer in Brazil. Sao Paulo Med J. 2004;122(5):188-94. DOI:10.1590/S1516-31802004000500002. |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Faculdade de Saúde Pública da Universidade de São Paulo |
publisher.none.fl_str_mv |
Faculdade de Saúde Pública da Universidade de São Paulo |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/6024/1/Cost%20of%20treating%20patients%20with%20smoking%20history%20in%20a%20specialized%20cancer%20hospital.pdf https://www.arca.fiocruz.br/bitstream/icict/6024/2/license.txt https://www.arca.fiocruz.br/bitstream/icict/6024/5/Cost%20of%20treating%20patients%20with%20smoking%20history%20in%20a%20specialized%20cancer%20hospital.pdf.txt https://www.arca.fiocruz.br/bitstream/icict/6024/4/Cost%20of%20treating%20patients%20with%20smoking%20history%20in%20a%20specialized%20cancer%20hospital.pdf.jpg |
bitstream.checksum.fl_str_mv |
7529a9774d646ed86751a0f636340181 7d48279ffeed55da8dfe2f8e81f3b81f b827bd69463c601c81ec4572f9775037 a4d1ac29d215d47317c4674238277399 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1798324653274431488 |